Actively Recruiting
Evaluating Clostridium Butyricum Versus Placebo for Anxiety and Depression in Functional Dyspepsia Patients Using Standard Treatments
Led by Xijing Hospital of Digestive Diseases · Updated on 2026-10-13
180
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether Clostridium butyricum can help reduce anxiety and depression symptoms in patients diagnosed with functional dyspepsia FD according to the Rome IV criteria. The study is designed as a double-blind, placebo-controlled clinical trial enrolling 180 participants, focusing on improving mental health alongside standard FD treatments. This phase 4 trial aims to provide more evidence on managing anxiety and depression in FD patients using probiotics.
CONDITIONS
Brief Title
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia
Research Team
Y
Yongquan Shi Shi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here